| |
|
|
|
CfPA-The Center for Professional Advancement, 90 Minute Accredited Online Training
October 30, 2014 at 11:00 a.m.–12:30 p.m. (ET)
Who Should Attend
This course is intended for all personnel involved with the following areas of pharmaceutical and medical device sterile facilities:
• Design
• Construction
• Validation
• Operation
• Monitoring
Other personnel who will find this course of interest:
• Design Engineers
• Test Contractors
• Equipment Manufacturers
• QA/QC
• Regulatory Affairs
• Production
• Maintenance Description
This course will be available On Demand: October 31, 2014
This 90-minute accredited training will offer a basic understanding of the Clean Room concept and will focus on the why and how a clean room is obtained and maintained. The classifications, design, layout and construction material of a clean room will also be discussed. Special attention will be given to the importance of proper personnel training, isolators, and the proper flow of material to and from a clean room operation.
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
William G. Marshall, President of William G. Marshall and Associates; Consultant to the worldwide drug and device industry as well as to the FDA and worldwide lecturer in GMP related issues.
William G. Marshall is President of William G. Marshall and Associates. He has over twenty years experience in the Pharmaceutical and Medical Device Manufacturing Environment. Mr. Marshall has held Director level and Chief Operating Officer positions with large multinational pharmaceutical corporations as well as start-up ventures. He has been the Director of a major reference laboratory, and has been active in clean room design and validation. In the last five years, he has acted as a third party in several consent decrees.
Mr. Marshall is currently a consultant to the worldwide drug and device industry as well as to the FDA. He lectures worldwide in GMP related issues including Clean Room Technology and Sterilization. In the past 18 months, he has been involved in 10 Pre-Approval Inspections that include the first aseptic processed injectables from India, the first ever drugs from Turkey, and APIs from China, that were all approved for introduction to the US market. He has a Master’s Degree in Biology from Georgetown University, Washington, DC.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
na
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|